Ovarian cancer · 20 regimens
Cost vs Efficacy · 9 points
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Carboplatin and Paclitaxel (CP) and Bevacizumab Variant #12 | — | R 45 174 | 21d | 14.1 mo | 43.4 mo | 21 | R 948 659 PFS proxy | 9 |
Carboplatin and Pegylated liposomal doxorubicin Variant #01 | — | R 14 626 | 28d | 19.0 mo | — | 21 | R 307 138 PFS proxy | 1 |
Carboplatin and Paclitaxel (CP) and Nintedanib Variant #01 | — | R 9 545 | 21d | 17.2 mo | — | 25 | R 238 614 PFS proxy | 1 |
Carboplatin and Paclitaxel (CP) Variant #38 | — | R 5 031 | 21d | 17.2 mo | 40.6 mo | 25 | R 125 768 PFS proxy | 21 |
Carboplatin and Gemcitabine (GCb) Variant #01 | — | R 3 663 | 21d | 20.0 mo | — | 29 | R 106 228 PFS proxy | — |
Carboplatin and Docetaxel (DCb) Variant #01 | — | R 3 300 | 21d | ~4.7 mo | ~22.3 mo | ~7 | ~R 23 101 PFS proxy · indirect | 4 |
CEP Variant #01 | — | R 2 001 | 28d | — | — | — | — | — |
Carboplatin monotherapy Variant #01 | — | R 1 231 | 21d | 12.1 mo | 33.0 mo | 18 | R 22 153 PFS proxy | 2 |
Carboplatin and Cyclophosphamide Variant #01 | — | R 1 052 | 28d | — | — | — | — | — |
Chlorambucil and Cisplatin Variant #01 | — | R 983 | 21d | — | — | — | — | — |
Cisplatin and Paclitaxel (TP) Variant #01 | — | R 716 | 10d | 16.4 mo | 36.8 mo | 50 | R 35 810 PFS proxy | 2 |
Cisplatin and Cyclophosphamide Variant #01 | — | R 679 | 21d | — | — | — | — | — |
CISCA Variant #02 | — | R 678 | 21d | — | — | — | — | — |
Cisplatin monotherapy Variant #16 | — | R 650 | 28d | — | ~19.5 mo | — | — | 1 |
Cisplatin, Cyclophosphamide, Interferon gamma-1b Variant #01 Partial | — | R 643 | 28d | — | — | — | — | — |
CHAD Variant #01 Partial | — | R 632 | 28d | — | — | — | — | — |
Hexa-CAF Variant #01 Partial | — | R 501 | 28d | — | — | — | — | — |
Altretamine and Cisplatin (HD) Variant #01 Partial | — | R 188 | 21d | — | — | — | — | — |
Melphalan monotherapy Variant #01 | — | R 71 | 42d | ~50.0 mo | ~22.2 mo | ~37 | ~R 2 636 PFS proxy · indirect | 7 |
CAP (Platinol) Partial | — | — | — | — | — | — | — | — |
20 of 20 regimens shown